DLL3 and neoplasm: In contrast, a much smaller study that examined DLL3 expression in 30 paired chemotherapy-naïve and chemotherapy-relapsed SCLC tumor samples found that DLL3 expression increased or decreased following chemotherapy in more than 40% of samples [28].